Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 16p12 2 Microdeletion Syndrome C4708497
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 16p12 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
16p12 2 Microdeletion Syndrome C4708497
A rare genetic condition where a small piece of chromosome 16 is missing. It can cause developmental delays, intellectual disability, and recurrent infections in some individuals. Treatment involves supportive therapies and medical management of symptoms.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
16p12 2 Microdeletion Syndrome C4708497
0-5
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
16p12 2 Microdeletion Syndrome C4708497
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
16p12 2 Microdeletion Syndrome C4708497
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
16p12 2 Microdeletion Syndrome C4708497
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
16p12 2 Microdeletion Syndrome C4708497
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
16p12 2 Microdeletion Syndrome C4708497
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 16p12-2-microdeletion-syndrome-C4708497 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16p12 2 Microdeletion Syndrome C4708497 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described with developmental delay and intellectual disability; supplied severity is severe. | May cause developmental delay and intellectual disability; supplied severity is moderate. | Moderate |
| Facial appearance | Distinctive facial features are mentioned, but specific features are not established here. | Distinctive facial findings are not described in the supplied source. | Low |
| Recurrent infections | Recurrent infection is not described in the supplied source. | Recurrent infections may occur in some individuals, but frequency is not established. | Moderate |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
Testing identifies the specified chromosome 21/11q22.12 deletion
The named chromosomal region is the defining evidence for this concept.
High
Severe congenital developmental findings are present
This matches the supplied severe, birth-onset description, but is not diagnostic alone.
Moderate
Distinctive facial features accompany developmental disability
This is mentioned for the left concept, although exact features are not established.
Low
Choose 16p12 2 Microdeletion Syndrome C4708497 when
Testing identifies a 16p12.2 microdeletion
A confirmed deletion at this locus defines the right concept.
High
Moderate delay is recognized from birth to age five
The supplied onset and severity differ from the left concept.
Moderate
Recurrent infections occur with developmental disability
Infections are mentioned for some people with the right concept, not as a sole diagnosis.
Moderate
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16p12 2 Microdeletion Syndrome C4708497 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving the specified 21q22/11q22.12 region. | Deletion involving 16p12.2. | The locus distinguishes the concepts; clinical correlation remains necessary. |
| Karyotype | A small deletion may not be visible. | A small deletion may not be visible. | A normal karyotype does not exclude either microdeletion. |
| Infection evaluation | No characteristic infection pattern is established. | Recurrent infections may be found in some individuals. | Infections support clinical assessment but do not establish the diagnosis. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- A chronic course is described, but survival and functional outcomes are not established.
- Factors
- Supplied severity is severe; developmental needs and associated findings may influence support.
16p12 2 Microdeletion Syndrome C4708497
- Outcome
- A chronic, generally moderate course is suggested, with substantial individual variation.
- Factors
- Developmental profile and recurrent infections in some people may affect needs.
Time frame: From birth or early childhood across the lifespan; precise milestones are not established.
Confirmed locus, associated medical findings, therapies, and clinician assessment determine planning.
Complications comparison
| Complication | Presentation |
|---|---|
| Intellectual disability | Described and categorized as severe in the source. Described, with moderate supplied severity and likely individual variation. Degree and functional impact require individualized assessment. |
| Recurrent infection | Not established from the supplied description. Reported in some individuals, without a defined frequency. An abnormal infection history is not itself a genetic diagnosis. |
| Long-term support needs | Chronic developmental support and medical monitoring are emphasized. Chronic supportive therapies and symptom management are emphasized. Neither course is communicable; exact outcomes are not established. |
Patient education highlights
- HighGenetic confirmation
A clinician should interpret chromosomal testing; symptoms alone cannot reliably separate these rare conditions.
- MediumSupportive care
Care generally focuses on development, learning, and monitoring of individual medical problems.
- LowTransmission
Neither condition is communicable. Inheritance counseling depends on confirmed genetic results.